With a new online resource, Eisai is offering patients and caregivers some direction to help navigate a kidney cancer ...
PARIS, March 3, 2026 /PRNewswire/ -- Expandi Limited today announced the acquisition of 100% of Kompass in a transformational ...
Eisai Inc. announced today the launch of Kompass ( a first-of-its-kind digital destination designed to help those affected by ...
Eisai has a position in kidney cancer with Lenvima (lenvatinib), a kinase inhibitor that is approved for use in combination ...
European marketing and ad tech vendor Expandi has partnered with veteran b2b data firm Kompass, integrating intent signals, corporate information, AI and other tech with the promise of 'redefining how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results